Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017

  • January 2017 •
  • Report ID: 3895250 •
  • Format: PDF
Fore Pharma announced the results of its Gastric Cancer patients study in a new report ‘Global Gastric Cancer Epidemiology and Patient Flow Analysis - 2017’.

The report provides insights into Gastric Cancer epidemiology, Gastric Cancer diagnosed patients, and Gastric Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Gastric Cancer derived from epidemiological analysis, percentage of patients diagnosed with Gastric Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Gastric Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Gastric Cancer prevalence, Gastric Cancer diagnosis rate, and Gastric Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Gastric Cancer Patient Flow
- Gastric Cancer Prevalence
- Gastric Cancer Diagnosed Patients
- Gastric Cancer Treated Patients